Manufacturing, Monoclonal Antibodies

SBIR Awards $1.4-Million Grant to Accelerate Antibody Manufacturing Technology

August 07, 2020

The award will help a bioanalytics startup commercialize instrument technology for pharmaceutical antibody manufacturers.

Points to Consider for Continuous Downstream Bioprocessing

August 01, 2020

It is critical to evaluate specific considerations, from design to application, for the benefit of downstream bioprocessing and manufacturing.

CureVac Receives Funding, Collaborates with GSK on mRNA and mAbs

July 21, 2020

GSK and CureVac will collaborate on mRNA-based vaccines and mAbs. Separately, the EIB and others provided CureVac with financing for development of its CVnCoV vaccine candidate and expansion of manufacturing.

CureVac Receives Funding, Collaborates with GSK on mRNA and mAbs

July 21, 2020

GSK and CureVac will collaborate on mRNA-based vaccines and mAbs. Separately, the EIB and others provided CureVac with financing for development of its CVnCoV vaccine candidate and expansion of manufacturing.

BARDA, DOD Award $450-Million COVID-19 Manufacturing and Supply Contract to Regeneron

July 08, 2020

BARDA and DOD have awarded a $450-million contract to Regeneron Pharmaceuticals to manufacture and supply an investigational double antibody cocktail in development for treating COVID-19.

FDA Grants Orphan Drug Designation to Prestige BioPharma’s Anti-Cancer mAb

July 01, 2020

While there currently is no molecular therapy targeted against the PAUFgene, Prestige believes its monoclonal antibody has the potential to benefit patients affected by PAUF-positive pancreatic cancer.

Lonza, Anthos Therapeutics Partner on Anti-coagulant Biologic Abelacimab

June 11, 2020

The companies have entered into a development and manufacturing agreement for Anthos Therapeutics’ abelacimab for treating thrombotic disorders.

Ajinomoto Bio-Pharma Services, CytoDyn in Manufacturing Partnership for COVID-19 Drug

May 05, 2020

The companies have entered into a manufacturing agreement to supply leronlimab, an investigational new drug currently being used in clinical trial protocols for COVID-19.

Immutep, Batavia Biosciences Generate High-Yielding LAG-3 Cell Line

April 16, 2020

This milestone achievement will allow the companies to move forward with developing a GMP-compliant manufacturing process for clinical testing.

Absolute Antibody Launches New, High-Throughput Recombinant Antibody Production Service

March 05, 2020

The technology enables the rapid production of large numbers of recombinant antibodies at 80-mL scale.